Hydroxyethyl Starch 130/0.4 Inhibits Production of Plasma Proinflammatory Cytokines and Attenuates Nuclear Factor-κB Activation and Toll-Like Receptors Expression in Monocytes During Sepsis

Journal of Surgical Research

Volumn 160, Issue 1, 2010, Pages 133-138

  Xie, Junran ^a   Lv, Ran ^a   Yu, Lina ^b   Huang, Weidong ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c First Affiliated Hospital   (China)

Author keywords

hydroxyethyl starch; NF B; sepsis; toll like receptors

Indexed keywords

CYTOKINE; HEMATOLOGIC AGENT; HYDROXYETHYL STARCH 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SEPSIS;

ANIMALS; CECUM; CYTOKINES; HEMODYNAMICS; HETASTARCH; INTERLEUKIN-6; LACTIC ACID; LIGATION; MALE; MONOCYTES; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEPSIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950187259     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.05.050     Document Type: Article

References (22)

1. Dulu A.O., and Haupt M.T. Fluid therapy continues to be validated in early sepsis: Impact on myocardial depression. Crit Care Med 35 (2007) 1435
2. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34 (2008) 17
3. Langeron O., Doelberg M., Ang E.T., et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92 (2001) 855
4. Feng X., Yan W., Liu X., et al. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-κB activation in CLP-induced sepsis in rats. J Surg Res 135 (2006) 129
5. Lee C.C., Chang I.J., Yen Z.S., et al. Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock. Shock 24 (2005) 177
6. Dieterich H.J., Weissmüller T., Rosenberger P., et al. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 34 (2006) 1775
7. Lv R., Zhou W., Chu C., et al. Mechanism of the effect of hydroxyethyl starch on reducing pulmonary capillary permeability in a rat model of sepsis. Ann Clin Lab Sci 35 (2005) 174
8. Lv R., Zhou Z.Q., Wu H.W., et al. Hydroxyethyl starch exhibitsantiinflammatory effects in the intestines of endotoxemic rats. Anesth Analg 103 (2006) 149
9. Brown M.A., and Jones W.K. NF-κB action in sepsis: The innate immune system and the heart. Front Biosci 9 (2004) 1201
10. Li Q., and Verma I.M. NF-κB regulation in the immune system. Nat Rev Immunol 2 (2002) 725
11. Feng X., Yan W., Wang Z., et al. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg 104 (2007) 624
12. Villa P., Sartor G., Angelini M., et al. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 2 (1995) 549
13. Neff T.A., Fischler L., Mark M., et al. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 100 (2005) 1773
14. Futamura Y. Age-associated changes in tumor necrosis factor alpha receptor on peripheral blood monocytes and bone marrow macrophages from ICR mice and Wistar rats. Exp Anim 44 (1995) 151
15. Riedemann N.C., Guo R.F., and Ward P.A. The enigma of sepsis. J Clin Invest 112 (2003) 460
16. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138
17. Liu S.F., and Malik A.B. NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290 (2006) L622
18. Uwe S. Anti-inflammatory interventions of NF-κB signaling: Potential applications and risks. Biochem Pharmacol 75 (2008) 1567
19. Tsai M.C., Chen W.J., Ching C.H., et al. Resuscitation with hydroxyethyl starch solution prevents nuclear factor κB activation and oxidative stress after hemorrhagic shock and resuscitation in rats. Shock 27 (2007) 527
20. Boldt J. New light on intravascular volume replacement regimens: What did we learn from the past three years?. Anesth Analg 97 (2003) 1595
21. Lang K., Boldt J., Suttner S., et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 93 (2001) 405
22. Lang K., Suttner S., Boldt J., et al. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anaesth 50 (2003) 1009